Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer
Marta Canel, Aleksandra Dominika Sławińska, David W. Lonergan, et al.
Gut (2023) Vol. 73, Iss. 1, pp. 131-155
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Roles and inhibitors of FAK in cancer: current advances and future directions
Hui-Hui Hu, Saiqi Wang, Hai-Li Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 24
CAF-induced physical constraints controlling T cell state and localization in solid tumours
Ludovica Arpinati, Giulia Carradori, Ruth Scherz‐Shouval
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 676-693
Closed Access | Times Cited: 13
Targeting Focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders
Xiao Wang, Na Li, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116678-116678
Closed Access | Times Cited: 11
CRISPR/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications
Xiaohang Feng, Z Y Li, Yuping Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges
Julianne M. Szczepanski, Mark A. Rudolf, Jiaqi Shi
Cancers (2024) Vol. 16, Iss. 4, pp. 794-794
Open Access | Times Cited: 7
Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells
Pingshan Zhong, Kohei Nakata, Koki Oyama, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches
Ming Gu, Yang Liu, Xin Peng, et al.
Cancer Letters (2024) Vol. 588, pp. 216738-216738
Closed Access | Times Cited: 6
Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study
Jiaming Gao, Jingwen Cheng, Wanyu Xie, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 639-651
Closed Access | Times Cited: 6
Exploring the Therapeutic Potential of Focal Adhesion Kinase Inhibition in Overcoming Chemoresistance in Pancreatic Ductal Adenocarcinoma
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 271-289
Closed Access | Times Cited: 5
Tumor Microenvironment: Nurturing Cancer Cells for Immunoevasion and Druggable Vulnerabilities for Cancer Immunotherapy
Hongyang Yu, Jinyang Li, Shiyin Peng, et al.
Cancer Letters (2024) Vol. 611, pp. 217385-217385
Closed Access | Times Cited: 5
GPR55 in the tumor microenvironment of pancreatic cancer controls tumorigenesis
Dušica Ristić, Thomas Bärnthaler, Eva Gruden, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Therapeutic potential of isochlorogenic acid A from Taraxacum officinale in improving immune response and enhancing the efficacy of PD-1/PD-L1 blockade in triple-negative breast cancer
Tianyun Wang, Jingwei Sun, Li Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Focal adhesion kinase-mediated interaction between tumor and immune cells in the tumor microenvironment: implications for cancer-associated therapies and tumor progression
Louis Boafo Kwantwi, Theophilus Tandoh
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 4
CMSS1: A RNA binding protein with pivotal roles in non-small cell lung cancer progression and prognosis
Zhe Fan, Wanyu Liu, Zhiwei Gao, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Prognostic value and immunotherapy analysis of immune cell-related genes in laryngeal cancer
Sen Zhang, Jianrui Pan, Huina Guo, et al.
PeerJ (2025) Vol. 13, pp. e19239-e19239
Open Access
Pan-cancer analysis of ABCC1 as a potential prognostic and immunological biomarker
Tiantian Wang, Dean Rao, Chenan Fu, et al.
Translational Oncology (2024) Vol. 41, pp. 101882-101882
Open Access | Times Cited: 3
FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis
Dan Su, Ruobing Wang, Guangyu Chen, et al.
Cancer Research (2024) Vol. 84, Iss. 16, pp. 2607-2625
Closed Access | Times Cited: 3
Focal adhesion kinase signaling – tumor vulnerabilities and clinical opportunities
David D. Schlaepfer, Marjaana Ojalill, Dwayne G. Stupack
Journal of Cell Science (2024) Vol. 137, Iss. 14
Open Access | Times Cited: 2
Immunoproteasome acted as immunotherapy ‘coffee companion’ in advanced carcinoma therapy
Shaoyan Shi, Xuehai Ou, Chao Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
New insights into SYK targeting in solid tumors
Shweta Joshi
Trends in Pharmacological Sciences (2024)
Closed Access | Times Cited: 2
Innovative theranostic hydrogels for targeted gastrointestinal cancer treatment
Min Tang, Jia Song, Shuyi Zhang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Identification of ONECUT3 as a stemness-related transcription factor regulating NK cell-mediated immune evasion in pancreatic cancer
Haojun Shi, Yiusing Tsang, Yisi Yang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
Masahiro Uehara, Takahiro Domoto, Satoshi Takenaka, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
Unveiling the Promise: Navigating Clinical Trials 1978–2024 for PDAC
A. Domínguez, M Perz, Yi Xu, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3564-3564
Open Access | Times Cited: 1
The integrin adhesome and control of anti-tumour immunity
Emily R. Webb, Annabel Black, Nicole D. Barth, et al.
Biochemical Society Transactions (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top